Complex glycan utilization by human gut Bacteroides
Complex glycan utilization by human gut Bacteroides
批准号:
8449162
负责人:
Eric C Martens
金额:
$9.4万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-15 至 2014-03-31
关键词:
AddressBacteriaBacteroidesBacteroides thetaiotaomicronBiologicalCarbohydratesCarbonCell WallCellsComplexCrowdingDataDevelopment PlansDietDietary PolysaccharideDisadvantagedEcosystemElementsEngineeringEnvironmentEvolutionFoundationsGenesGenomeGenomicsGnotobioticHandHarvestHumanIndividualInstructionInvestigationKnowledgeMentorsMetabolismMolecularMolecular GeneticsMonosaccharidesMucinsMucous MembraneMusNutrientOrganismParentsPhenotypePhysiologicalPhysiologyPlantsPolysaccharidesProcessResearchResearch ProposalsSchemeShapesSourceTestingTrainingUniversitiesWashingtonbasecareercareer developmentexperiencefeedingfitnessgut microbiotahemicellulosein vivomedical schoolsmembermicrobialmicrobiomemutantnutritionprofessortool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The human gut microbiota provides physiologic attributes that we have not had to evolve on our own,
including the ability to process otherwise indigestible dietary glycans. Bacteroides thetaiotaomicron {B. theta)
and Bacteroides ovatus, two members of the microbiota, have diverse but only partially overlapping abilities
to process dietary and host-derived glycans - evolved features that likely influence their fitness in the
crowded gut ecosystem. At least one of these organisms, 6. f/iefa, prioritizes metabolism of plant pectic
glycans over host mucin glycans, suggesting that it has evolved to avoid using the host mucosa as a nutrient
base when dietary glycans are abundant. I will define and compare the carbohydrate utilization hierarchies
of these two species to determine if they evolved the same or different priorities. Moreover, I will explore the
molecular mechanisms that underlie glycan prioritization in B. tfieta, allowing me to test the fitness value of
this phenomenon in vivo in the gnotobiotic mouse gut. I will also explore the mechanisms through which 6.
ovatus targets the abundant and sometimes less soluble hemicellulose class of plant cell wall glycans, a
group of substrates that B. theta is not able to metabolize. Deletion of hemicellulose utilization genes from
the S. ovatus genome followed by in vivo competition of the resulting hemicellulose-deficient mutants with
their isogenic parents, will reveal if expression of these phenotypes provides a fitness advantage or
disadvantage in gnotobiotic mice fed a diet rich in these substrates. Finally, I will explore the possibility that
glycan utilization phenotypes can be laterally transferred between Bacteroides species, a phenomenon that
our data suggest occurs naturally. Support of this hypothesis will yield fundamental mechanistic information
about genomic evolution of glycan utilization among microbiota bacteria. My current training environment,
Jeffrey Gordon's lab at Washington University Medical School, provides a unique place to begin this
research and may be the only lab in the world equipped with all of the necessary tools to answer the
experimental questions at hand. My career development plan includes building a robust research foundation
in the Gordon lab and transitioning into an independent career as a tenure track Assistant Professor. The
experimental and professional training achieved during this mentored research proposal will provide the
experience I need to be successful on my own.
RELEVANCE (See instructions):
Human gut bacteria are essential for the transformation of complex dietary polysaccharides, many of which
we cannot digest on our own, into forms that we readily absorb. I will characterize the dynamic
interrelationships between abundant plant glycans that enter our diets and the physiology and evolution of
our gut bacteria. The results will reveal which dietary glycans bacteria 'can' metabolize and which ones they
'want' to metabolize, providing new knowledge about how our gut microbiota harvests dietary nutrients.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1128/mbio.01441-14
发表时间:
2014-09-09
期刊:
mBio
影响因子:
6.4
作者:
[Cameron EA, Kwiatkowski KJ, Lee BH, Hamaker BR, Koropatkin NM, Martens EC]
通讯作者:
Martens EC
DOI:
10.1038/nature12907
发表时间:
2014-02-27
期刊:
Nature
影响因子:
64.8
作者:
[]
通讯作者:
DOI:
10.1016/j.jmb.2014.06.022
发表时间:
2014-11-25
期刊:
JOURNAL OF MOLECULAR BIOLOGY
影响因子:
5.6
作者:
[Martens, Eric C., Kelly, Amelia G., Tauzin, Alexandra S., Brumer, Harry]
通讯作者:
Brumer, Harry
DOI:
10.1128/mbio.01282-15
发表时间:
2015-11-10
期刊:
mBio
影响因子:
6.4
作者:
[Pudlo NA, Urs K, Kumar SS, German JB, Mills DA, Martens EC]
通讯作者:
Martens EC
Gnotobiotics mice and bacterial cultures phenotyping core
-
批准号:10241903
-
项目类别:
-
资助金额:$21.55万
-
财政年份:2020
-
负责人:Eric C Martens
-
依托单位:
Gnotobiotics mice and bacterial cultures phenotyping core
-
批准号:10441577
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2020
-
负责人:Eric C Martens
-
依托单位:
Gnotobiotics mice and bacterial cultures phenotyping core
-
批准号:10650309
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2020
-
负责人:Eric C Martens
-
依托单位:
Low dietary fiber and gut microbiota-induced mucus layer erosion as IBD triggers
-
批准号:9900776
-
项目类别:
-
资助金额:$54.29万
-
财政年份:2018
-
负责人:Eric C Martens
-
依托单位:
How glycans shape gut microbiota function and assembly
-
批准号:8617284
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2013
-
负责人:Eric C Martens
-
依托单位:
How glycans shape gut microbiota function and assembly
-
批准号:8411477
-
项目类别:
-
资助金额:$30.27万
-
财政年份:2013
-
负责人:Eric C Martens
-
依托单位:
How glycans shape gut microbiota function and assembly
-
批准号:8811444
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2013
-
负责人:Eric C Martens
-
依托单位:
The role of polysaccharide surface capsules in Bacteroides glycan degradation
-
批准号:8354382
-
项目类别:
-
资助金额:$8.06万
-
财政年份:2012
-
负责人:Eric C Martens
-
依托单位:
The role of polysaccharide surface capsules in Bacteroides glycan degradation
-
批准号:8534779
-
项目类别:
-
资助金额:$6.89万
-
财政年份:2012
-
负责人:Eric C Martens
-
依托单位:
Complex glycan utilization by human gut Bacteroides
-
批准号:8055482
-
项目类别:
-
资助金额:$12.75万
-
财政年份:2009
-
负责人:Eric C Martens
-
依托单位:
Complex glycan utilization by human gut Bacteroides
-
批准号:8249460
-
项目类别:
-
资助金额:$12.75万
-
财政年份:2009
-
负责人:Eric C Martens
-
依托单位:
Complex glycan utilization by human gut Bacteroides
-
批准号:7713811
-
项目类别:
-
资助金额:$2.76万
-
财政年份:2009
-
负责人:Eric C Martens
-
依托单位:
Complex glycan utilization by human gut Bacteroides
-
批准号:7870323
-
项目类别:
-
资助金额:$12.46万
-
财政年份:2009
-
负责人:Eric C Martens
-
依托单位:
Complex glycan utilization by human gut Bacteroides
-
批准号:8032680
-
项目类别:
-
资助金额:$8.23万
-
财政年份:2009
-
负责人:Eric C Martens
-
依托单位:
Sensing and Utilization of Mucopolysaccharides by Bacteroides thetaiotaomicron
-
批准号:7430401
-
项目类别:
-
资助金额:$4.96万
-
财政年份:2007
-
负责人:Eric C Martens
-
依托单位:
Sensing and Utilization of Mucopolysaccharides by Bacteroides thetaiotaomicron
-
批准号:7221012
-
项目类别:
-
资助金额:$4.68万
-
财政年份:2007
-
负责人:Eric C Martens
-
依托单位:
国内基金
海外基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
-
批准号:81971557
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2019
-
负责人:毛开睿
-
依托单位:
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
-
批准号:51678163
-
项目类别:面上项目
-
资助金额:64.0万元
-
批准年份:2016
-
负责人:许玫英
-
依托单位: